Management Options for Malignant Pleural Mesothelioma: Clinical and Cost Considerations

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.8, 2007-01, pp. : 1149-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 824-849

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed/cisplatin worth it in malignant pleural mesothelioma

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Current chemotherapeutic treatment of malignant pleural mesothelioma

By Nowak Anna K Byrne Michael J Millward Michael J Alvarez John M Robinson Bruce WS

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2441-2449

Informa Healthcare

Access to resources Recommend Favorite

Malignant pleural mesothelioma: current treatments and emerging drugs

By Belli Carmen Fennell Dean Giovannini Monica Gaudino Giovanni Mutti Luciano

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 423-437

Informa Healthcare

Access to resources Recommend Favorite

Raltitrexed + cisplatin beneficial for malignant pleural mesothelioma

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite